Holen Sie sich die Stockscreener-App
5.37
0.19%
-0.010
Schlusskurs vom Vortag:
$5.38
Offen:
$5.37
24-Stunden-Volumen:
462.18K
Relative Volume:
0.36
Marktkapitalisierung:
$467.17M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-69.31M
KGV:
-4.2283
EPS:
-1.27
Netto-Cashflow:
$-62.80M
1W Leistung:
+5.09%
1M Leistung:
+30.66%
6M Leistung:
+11.64%
1J Leistung:
+14.99%
1-Tages-Spanne:
$5.22
$5.445
1-Wochen-Bereich:
$5.10
$5.70
52-Wochen-Spanne:
$2.215
$6.1856
Rezolute Inc Stock (RZLT) Company Profile
Firmenname
Rezolute Inc
Sektor
Branche
Telefon
650-206-4507
Adresse
275 SHORELINE DRIVE, SUITE 500, REDWOOD CITY
Vergleichen Sie RZLT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RZLT
Rezolute Inc
|
5.37 | 443.62M | 0 | -69.31M | -62.80M | -1.27 |
|
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Rezolute Inc Stock (RZLT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-05 | Eingeleitet | Wedbush | Outperform |
| 2024-08-27 | Eingeleitet | Guggenheim | Buy |
| 2024-07-17 | Eingeleitet | BTIG Research | Buy |
| 2024-06-04 | Eingeleitet | Craig Hallum | Buy |
| 2024-04-09 | Eingeleitet | Maxim Group | Buy |
| 2022-08-02 | Fortgesetzt | Canaccord Genuity | Buy |
| 2022-06-15 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-09-08 | Eingeleitet | ROTH Capital | Buy |
| 2021-05-27 | Eingeleitet | Oppenheimer | Outperform |
| 2021-05-25 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Rezolute Inc Aktie (RZLT) Neueste Nachrichten
What analysts say about Rezolute Inc. stockUnprecedented growth rates - Autocar Professional
What drives Rezolute Inc. stock priceOutstanding capital appreciation - Autocar Professional
Is Rezolute Inc. a good long term investmentFree Risk Assessment Services - jammulinksnews.com
Rezolute Inc. Stock Analysis and ForecastConsistently profitable trades - jammulinksnews.com
Rezolute to Participate in the BTIG Virtual Biotechnology Conference - The Manila Times
Rezolute posts patient demographics poster for Phase 3 sunRIZE study - Investing.com
Rezolute posts patient demographics poster for Phase 3 sunRIZE study By Investing.com - Investing.com South Africa
Rezolute Completes Enrollment for Phase 3 sunRIZE Study - TipRanks
Rezolute, Inc. shares rise 1.08% after-hours after registering a secondary offering of 1.3 million shares. - AInvest
Craig-Hallum Maintains Rezolute(RZLT.US) With Buy Rating - 富途牛牛
Craig-Hallum Reaffirms Their Buy Rating on Rezolute (RZLT) - The Globe and Mail
What makes Rezolute Inc. stock price move sharplyPredictable Return Stock Picks - Newser
Why Rezolute Inc. stock attracts strong analyst attentionInstant Stock Updates - Newser
How Rezolute Inc. stock performs during market volatilityFree Trading Strategy Suggestions - Newser
Rezolute Announces Presentation of Participant Baseline Data From Its Fully Enrolled Phase 3 Study of Ersodetug in Congenital Hyperinsulinism at the Upcoming Annual Meeting of the Endocrine Society (ENDO 2025) - 富途牛牛
Rezolute, Inc. Announces Late-Breaking Presentation of Phase 3 Study Data for Ersodetug at ENDO 2025 - Quiver Quantitative
Rezolute Announces Presentation of Participant Baseline Data from its Fully Enrolled Phase 3 Study of Ersodetug in Congenital Hyperinsulinism at the Upcoming Annual Meeting of the Endocrine Society (ENDO 2025) - TradingView
Rezolute, Inc. (NASDAQ:RZLT) Receives Consensus Rating of “Buy” from Analysts - Defense World
Institutional investors must be pleased after a 11% gain last week that adds to Rezolute, Inc.'s (NASDAQ:RZLT) one-year returns - simplywall.st
Rezolute Inc: chief medical officer Roberts buys $10939 in shares - Investing.com
Rezolute CFO Evans buys $20,250 in company stock - Investing.com
Rezolute CFO Evans buys $20,250 in company stock By Investing.com - Investing.com India
Rezolute director Kim buys shares worth $3.99 million - Investing.com India
Rezolute, Inc. (NASDAQ:RZLT) Receives Consensus Recommendation of “Buy” from Analysts - Defense World
Rezolute’s SWOT analysis: ersodetug trials boost stock amid clinical milestones - Investing.com India
Bank of America Corp DE Has $443,000 Stock Position in Rezolute, Inc. (NASDAQ:RZLT) - Defense World
Two Sigma Investments LP Sells 12,118 Shares of Rezolute, Inc. (NASDAQ:RZLT) - Defense World
Squarepoint Ops LLC Sells 3,980 Shares of Rezolute, Inc. (NASDAQ:RZLT) - Defense World
Millennium Management LLC Decreases Stake in Rezolute, Inc. (NASDAQ:RZLT) - Defense World
69,724 Shares in Rezolute, Inc. (NASDAQ:RZLT) Bought by Ameriprise Financial Inc. - Defense World
Rezolute, Inc. (NASDAQ:RZLT) is a favorite amongst institutional investors who own 77% - Yahoo Finance
BTIG maintains $15 target on Rezolute stock following trial update - Investing.com Australia
BTIG maintains $15 target on Rezolute stock following trial update By Investing.com - Investing.com India
Rezolute Announces Completion Of Enrollment In The Phase 3 Sunrize Study Of Ersodetug In Patients With Congenital Hyperinsulinism - marketscreener.com
Rezolute complete enrollment in Phase 3 sunRIZE study of ersodetug - TipRanks
Rezolute (RZLT) Completes Enrollment for Pivotal sunRIZE Study | - GuruFocus
Rezolute (RZLT) Completes Enrollment for Pivotal sunRIZE Study | RZLT Stock News - GuruFocus
Rezolute Announces Completion of Enrollment in the Phase 3 sunRIZE Study of Ersodetug in Patients with Congenital Hyperinsulinism - The Manila Times
Finanzdaten der Rezolute Inc-Aktie (RZLT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):